← Back to Search

Orthopedic Implant

APEX Modular for Osteoarthritis

N/A
Waitlist Available
Led By David F Scott, MD
Research Sponsored by Spokane Joint Replacement Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative
Awards & highlights
No Placebo-Only Group

Summary

This study compares the change in bone density which occurs after hip replacement with different femoral stem devices.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Femoral bone mineral density
Secondary study objectives
Harris Hip Score (HHS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: ARC StemExperimental Treatment1 Intervention
ARC Stem group
Group II: APEX ModularExperimental Treatment1 Intervention
APEX Modular Stem group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OMNI Apex ARC™ Hip Device
2009
N/A
~80
OMNI Apex Modular™ Hip Device
2009
N/A
~80

Find a Location

Who is running the clinical trial?

Spokane Joint Replacement CenterLead Sponsor
5 Previous Clinical Trials
10,276 Total Patients Enrolled
3 Trials studying Osteoarthritis
10,194 Patients Enrolled for Osteoarthritis
David F Scott, MDPrincipal InvestigatorSpokane Joint Replacement Center
3 Previous Clinical Trials
294 Total Patients Enrolled
3 Trials studying Osteoarthritis
294 Patients Enrolled for Osteoarthritis
~5 spots leftby Nov 2025